|
JPS506987B1
(https=)
|
1970-02-17 |
1975-03-19 |
|
|
|
JPS4918630B1
(https=)
|
1970-07-29 |
1974-05-11 |
|
|
|
JPS5859712U
(ja)
|
1981-10-16 |
1983-04-22 |
ニチバン株式会社 |
ラベル貼付機
|
|
JPH0892090A
(ja)
|
1994-07-26 |
1996-04-09 |
Tanabe Seiyaku Co Ltd |
医薬組成物
|
|
EP0695755B1
(en)
|
1994-08-04 |
1998-10-21 |
F. Hoffmann-La Roche AG |
Pyrrolocarbazole
|
|
EA001450B1
(ru)
|
1996-05-01 |
2001-04-23 |
Эли Лилли Энд Компани |
Галогензамещенные ингибиторы протеинкиназы с
|
|
ES2292262T3
(es)
*
|
1998-12-24 |
2008-03-01 |
Astellas Pharma Inc. |
Compuestos de imidazol y su uso medicinal.
|
|
EP1178988B1
(en)
|
1999-05-14 |
2007-02-28 |
The Australian National University |
Compounds and therapeutic methods
|
|
GB0030417D0
(en)
|
2000-12-13 |
2001-01-24 |
Pharma Mar Sa |
An anticancer lead compound isolated from a New Zealand ascidian
|
|
FR2841138B1
(fr)
|
2002-06-25 |
2005-02-25 |
Cll Pharma |
Composition pharmaceutique solide contenant un principe actif lipophile, son procede de preparation
|
|
EP1603567A4
(en)
|
2003-02-28 |
2006-10-18 |
Inotek Pharmaceuticals Corp |
TETRACYCLIC BENZAMIDE DERIVATIVES AND METHOD OF USE THEREOF
|
|
ES2263862T3
(es)
|
2003-03-07 |
2006-12-16 |
Istituto Nazionale Per Lo Studio E La Cura Dei Tumori |
Ensayo de quinasa de linfoma anaplasico, sus reactivos y composiciones.
|
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
|
EP1648455A4
(en)
|
2003-07-23 |
2009-03-04 |
Exelixis Inc |
MODULATORS OF ALK PROTEIN (ANAPLASTIC LYMPHOMA KINASE) AND METHODS OF USE
|
|
US7378414B2
(en)
|
2003-08-25 |
2008-05-27 |
Abbott Laboratories |
Anti-infective agents
|
|
PT1687305E
(pt)
|
2003-11-21 |
2008-10-17 |
Novartis Ag |
Derivados de 1h-imidazoquinolina como inibidores de proteína quinase
|
|
JP2007513890A
(ja)
|
2003-12-12 |
2007-05-31 |
メルク フロスト カナダ リミテツド |
カテプシンシステインプロテアーゼ阻害剤
|
|
TW200609215A
(en)
|
2004-03-19 |
2006-03-16 |
Speedel Experimenta Ag |
Organic compounds
|
|
WO2005092062A2
(en)
*
|
2004-03-19 |
2005-10-06 |
Myriad Genetics, Inc. |
Compounds for neurodegenerative disorders
|
|
JP2008502595A
(ja)
|
2004-03-31 |
2008-01-31 |
エグゼリクシス， インコーポレイテッド |
未分化リンパ腫キナーゼモジュレータおよびその使用方法
|
|
MXPA06014066A
(es)
*
|
2004-06-02 |
2007-02-15 |
Pharmacyclics Inc |
Inhibicion de factor viia.
|
|
DE602005020465D1
(de)
|
2004-08-26 |
2010-05-20 |
Pfizer |
Enantiomerenreine aminoheteroaryl-verbindungen als proteinkinasehemmer
|
|
US7091202B2
(en)
|
2004-09-15 |
2006-08-15 |
Bristol-Myers Squibb Company |
4-arylspirocycloalkyl-2-aminopyrimidine carboxamide KCNQ potassium channel modulators
|
|
GB0517329D0
(en)
|
2005-08-25 |
2005-10-05 |
Merck Sharp & Dohme |
Stimulation of neurogenesis
|
|
RU2008122547A
(ru)
|
2005-11-07 |
2009-12-20 |
Айрм Ллк (Bm) |
Соединения и композиции как модуляторы арпп (активированных рецепторов пролифератора пероксисом)
|
|
US7601716B2
(en)
|
2006-05-01 |
2009-10-13 |
Cephalon, Inc. |
Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors
|
|
US8063225B2
(en)
|
2006-08-14 |
2011-11-22 |
Chembridge Corporation |
Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
|
|
ES2555803T3
(es)
|
2006-10-23 |
2016-01-08 |
Cephalon, Inc. |
Fusión de derivados bicíclicos 2,4-diaminopirimidina como utilizar inhibidores ALK y c-Met
|
|
EP2142551B1
(en)
|
2007-04-17 |
2015-10-14 |
Bristol-Myers Squibb Company |
Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type i inhibitors
|
|
TWI389893B
(zh)
|
2007-07-06 |
2013-03-21 |
Astellas Pharma Inc |
二（芳胺基）芳基化合物
|
|
PT2176231T
(pt)
|
2007-07-20 |
2016-12-09 |
Nerviano Medical Sciences Srl |
Derivados de indazol substituídos activos como inibidores de quinases
|
|
US10047066B2
(en)
|
2007-11-30 |
2018-08-14 |
Newlink Genetics Corporation |
IDO inhibitors
|
|
US20110038898A1
(en)
|
2008-03-13 |
2011-02-17 |
Shuichi Yada |
Dissolution properties of drug products containing olmesartan medoxomil
|
|
MX2011011661A
(es)
|
2009-05-07 |
2011-11-18 |
Astrazeneca Ab |
Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750.
|
|
US8609097B2
(en)
|
2009-06-10 |
2013-12-17 |
Hoffmann-La Roche Inc. |
Use of an anti-Tau pS422 antibody for the treatment of brain diseases
|
|
ES2575084T3
(es)
|
2009-06-10 |
2016-06-24 |
Chugai Seiyaku Kabushiki Kaisha |
Compuesto tetracíclico
|
|
GB0910046D0
(en)
|
2009-06-10 |
2009-07-22 |
Glaxosmithkline Biolog Sa |
Novel compositions
|
|
CN103052386B
(zh)
|
2010-08-20 |
2016-03-02 |
中外制药株式会社 |
含有四环化合物的组合物
|
|
JP5006987B2
(ja)
|
2010-11-22 |
2012-08-22 |
中外製薬株式会社 |
４環性化合物を含む医薬
|
|
MY170904A
(en)
|
2012-09-25 |
2019-09-13 |
Chugai Pharmaceutical Co Ltd |
Ret inhibitor
|
|
JP6873698B2
(ja)
|
2014-04-25 |
2021-05-19 |
中外製薬株式会社 |
４環性化合物の新規結晶
|
|
TWI831128B
(zh)
|
2014-04-25 |
2024-02-01 |
日商中外製藥股份有限公司 |
以高用量含有４環性化合物的製劑
|
|
WO2015193309A1
(en)
|
2014-06-18 |
2015-12-23 |
F. Hoffmann-La Roche Ag |
New pharmaceutical composition comprising non-ionic surfactants
|
|
TWI803187B
(zh)
|
2014-08-08 |
2023-05-21 |
日商中外製藥股份有限公司 |
包含４環性化合物的非晶質體之固體分散體及製劑
|
|
CN104402862B
(zh)
*
|
2014-11-12 |
2016-10-05 |
苏州明锐医药科技有限公司 |
艾立替尼的制备方法
|
|
US9573932B2
(en)
|
2015-03-02 |
2017-02-21 |
Yong Xu |
Synthesis of intermediates in the preparation of ALK inhibitor
|
|
WO2017073706A1
(ja)
*
|
2015-10-30 |
2017-05-04 |
中外製薬株式会社 |
ジヒドロナフト［２，３－ｂ］ベンゾフラン誘導体
|
|
CN106928184B
(zh)
*
|
2017-04-21 |
2019-09-20 |
湖南博奥德药业有限公司 |
一种艾乐替尼的制备方法
|
|
CN106928185B
(zh)
*
|
2017-04-21 |
2019-09-20 |
湖南博奥德药业有限公司 |
一种艾乐替尼的制备方法
|
|
CN107033124B
(zh)
*
|
2017-04-21 |
2019-09-20 |
湖南博奥德药业有限公司 |
一种艾乐替尼的制备方法
|